Λesnova Medical Aesthetics Summit: Pioneering New Frontiers

About HanKing

Shanghai HanKing—A Reliable Partner in Medical Aesthetics Technology

Shanghai Hanyao Instrument & Equipment Co., Ltd., with over a decade of deep-rooted expertise in the biopharmaceutical sector, precisely aligns its instruments and specialized technologies with the medical aesthetics industry. Centered around precision fermentation equipment, highly efficient purification systems, and comprehensive quality-control solutions, we provide robust support for the research and development and production of active ingredients used in medical aesthetics.

Leveraging our nationwide technical service network and a global, high-quality supply chain, we are helping numerous medical aesthetic enterprises break through technological bottlenecks and ensuring the efficiency, purity, and safety of products—from raw materials to finished goods. Looking ahead, Han Yao will continue to harness technology to empower the beauty industry and become a key driving force behind innovation and standard-setting in the medical aesthetics sector.

Exhibit Details

▌Jiewei Sterile Film Evaporator—The “High-Purity Guardian” of Medical Aesthetic Raw Materials

In the production of medical aesthetic raw materials, sterile thin-film evaporators can efficiently remove organic solvents from fermentation broths or synthetic reaction systems in a single, continuous process. They are particularly well-suited for concentrating and purifying heat-sensitive ingredients such as peptides, natural extracts, and biopolymers. Thanks to their low-temperature, high-efficiency evaporation characteristics, these evaporators protect active ingredients from degradation and inactivation. The sterile design further ensures that the product remains free from contamination throughout the purification process, meeting the stringent requirements for injectable-grade raw materials. Whether preparing high-purity hyaluronic acid or processing cell culture media, sterile thin-film evaporators deliver stable and reliable performance, providing solid assurance for the purity, activity, and safety of medical aesthetic raw materials.

▌Applikon BioBundles Glass Jar Bioreactor: A Precision Biomanufacturing Platform for Cosmetic Active Ingredients

In the biomanufacturing process of cosmetic and medical-grade raw materials, Applikon BioBundles glass-jar bioreactors—thanks to their modular integrated design and highly precise, controllable features—have become an ideal platform for the efficient production of active ingredients. Their integrated controllers enable real-time, accurate monitoring and regulation of critical parameters such as dissolved oxygen, pH, and temperature during the cultivation process, ensuring that engineered strains or cells consistently remain in an optimal metabolic state and efficiently synthesize high-value cosmetic active ingredients—including recombinant collagen, ectoine, and peptides. Meanwhile, the compatibility of the glass material and the sterile design effectively eliminate contamination risks, guaranteeing the purity and safety of the final products. With their reliable reproducibility and flexible scalability, Applikon BioBundles provide core technological support for the high-quality, stable, and large-scale production of cosmetic and medical-grade raw materials.

▌The Fully Automatic Peptide Synthesizer PurePep® Chorus—A Precision Synthesis Platform for Medical Aesthetic Peptide Raw Materials

Compared to conventional liquid-phase synthesis, the PTI fully automated peptide synthesizer demonstrates unique advantages in the preparation of cosmetic peptides used as raw materials in medical aesthetics. Utilizing fully automated solid-phase synthesis technology, this equipment precisely controls the amino acid coupling and modification processes, ensuring the sequence accuracy and structural integrity of highly active cosmetic peptides such as Acetyl Hexapeptide-8 and Palmitoyl Tripeptide-1. The resulting products achieve a stable purity level of over 98%, meeting the stringent standards required for medical aesthetic raw materials. Its closed-loop synthesis environment effectively minimizes contamination risks, while its modular design enables seamless scale-up from research and development to large-scale production. This provides the medical aesthetics industry with batch-stable and reliably high-quality cosmetic peptide raw materials, thereby supporting the innovative development of efficacy-driven skincare products.

▌Chromatographic Column: The “Precision Eye” of Medical Aesthetic Products

In today’s medical aesthetics industry, which strives for “precise ingredients, reliable efficacy, and controllable safety,” chromatographic columns—being the core of separation and analytical technologies—are quietly emerging as the “invisible engine” driving product innovation. From injectables to efficacy-focused skincare products, chromatographic technology permeates the entire chain—from research and development and production to quality control. Whether it’s the precise analysis of molecular structures, rigorous quality control throughout the manufacturing process, or the scientific validation behind claimed efficacy, chromatographic columns, with their unique ability to “reveal the truth through separation,” are becoming an indispensable technological cornerstone for the medical aesthetics industry’s journey toward greater scientific rigor, standardization, and high-end sophistication.

Frontier Forum

@Medical Beauty Innovation Practitioner:

On December 2-3, 2025, the Λesnova Medical Aesthetics Innovators Forum cordially invites both new and returning friends to gather in Shanghai and join over 2,000 innovators from across the entire medical aesthetics industry chain as we jointly embark on a new journey!

Gathering the industry’s top talents, this forum—serving as a specialized platform for exchanging insights into cutting-edge trends and technological breakthroughs in the medical aesthetics sector—has received strong support from industry leaders including Allergan Aesthetics, Huaxi Biologics, Sihuan Pharmaceutical, Jinbo Biotech, XinOxygen, Qizhi Laser, and Fumailai Medical.

The speakers include top executives from leading companies, senior clinical physicians, cutting-edge research experts, and representatives from renowned investment institutions. Drawing on their respective areas of expertise, they will share research findings, technological breakthroughs, market trends, and policy orientations in the medical aesthetics industry, providing attendees with comprehensive and multi-dimensional insights into the sector.

The forum features nine thematic agendas centered on the core directions of the medical aesthetics industry, focusing on hot industry topics and systematically exploring recent developments and applications in key areas such as injectable medical aesthetics, optoelectronic medical aesthetics, efficacy-based skincare, clinical practice, and investment & financing collaborations, thereby promoting the commercialization and practical implementation of medical aesthetic technologies. The forum aims to create an industry exchange platform guided by the principles of “technology implementation and a closed-loop business model,” showcasing innovative achievements and emerging trends across the upstream and downstream segments of the industrial chain.

Keywords:

Parallel Synthesis Technology: A Game Changer for Synthetic Experiments

Overcoming PNA Synthesis Challenges with the PurePep® Chorus Automated Peptide Synthesizer